David Kylhammar

1.1k total citations · 1 hit paper
22 papers, 710 citations indexed

About

David Kylhammar is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, David Kylhammar has authored 22 papers receiving a total of 710 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 10 papers in Cardiology and Cardiovascular Medicine and 5 papers in Genetics. Recurrent topics in David Kylhammar's work include Pulmonary Hypertension Research and Treatments (14 papers), Vascular Anomalies and Treatments (5 papers) and Nitric Oxide and Endothelin Effects (4 papers). David Kylhammar is often cited by papers focused on Pulmonary Hypertension Research and Treatments (14 papers), Vascular Anomalies and Treatments (5 papers) and Nitric Oxide and Endothelin Effects (4 papers). David Kylhammar collaborates with scholars based in Sweden and Denmark. David Kylhammar's co-authors include Göran Rådegran, Magnus Nisell, Clara Hjalmarsson, Barbro Kjellström, Stefan Söderberg, Gerhard Wikström, Kjell Jansson, Roger Hesselstrand, Bengt Rundqvist and Søren Nielsen and has published in prestigious journals such as European Heart Journal, Annals of the Rheumatic Diseases and European Respiratory Journal.

In The Last Decade

David Kylhammar

20 papers receiving 705 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension

2017 342 citations David Kylhammar, Barbro Kjellström et al. European Heart Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Kylhammar Sweden	13	638	441	111	73	59	22	710
Gideon Paul Canada	12	518 0.8×	483 1.1×	100 0.9×	44 0.6×	90 1.5×	21	754
Abigail Krichman United States	4	428 0.7×	325 0.7×	117 1.1×	69 0.9×	51 0.9×	5	516
Simon Jennings United Kingdom	4	544 0.9×	218 0.5×	58 0.5×	53 0.7×	97 1.6×	5	620
Roela Sadushi‐Kolici Austria	14	512 0.8×	409 0.9×	129 1.2×	33 0.5×	44 0.7×	28	606
Radhika Gaddipati United States	6	742 1.2×	147 0.3×	60 0.5×	38 0.5×	124 2.1×	8	854
Kathy Feldkircher United States	5	1.2k 1.9×	774 1.8×	288 2.6×	140 1.9×	102 1.7×	8	1.3k
LJ Rubin United States	2	626 1.0×	436 1.0×	122 1.1×	66 0.9×	30 0.5×	6	653
Abby Krichman United States	7	1.3k 2.1×	867 2.0×	308 2.8×	159 2.2×	144 2.4×	15	1.4k
Jason S. Fritz United States	11	466 0.7×	269 0.6×	64 0.6×	87 1.2×	72 1.2×	24	550
Rintaro Nishimura Japan	14	360 0.6×	172 0.4×	62 0.6×	16 0.2×	69 1.2×	37	545

Countries citing papers authored by David Kylhammar

Since Specialization

Citations

This map shows the geographic impact of David Kylhammar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Kylhammar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Kylhammar more than expected).

Fields of papers citing papers by David Kylhammar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Kylhammar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Kylhammar. The network helps show where David Kylhammar may publish in the future.

Co-authorship network of co-authors of David Kylhammar

This figure shows the co-authorship network connecting the top 25 collaborators of David Kylhammar. A scholar is included among the top collaborators of David Kylhammar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Kylhammar. David Kylhammar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zachrisson, Helene, et al.. (2025). Heterogeneous myocardial contraction detected by speckle tracking echocardiography in systemic lupus erythematosus is associated with complement protein C4: a cross-sectional study from a Swedish tertiary referral centre. Rheumatology International. 45(8). 183–183. 1 indexed citations

Kylhammar, David, Eva Swahn, Jan Engvall, et al.. (2025). Prevalence and common cardiovascular risk factors in aortic valve calcification in the middle-aged general population. European Journal of Preventive Cardiology. 32(17). 1694–1702. 1 indexed citations

Kylhammar, David, Fredrik Nilsson, Petter Dyverfeldt, et al.. (2025). Follow-up of incidentally detected mild to moderate ascending aortic dilation and risk factors for rapid progression in a Swedish middle-aged population. Heart. 111(19). 904–909. 1 indexed citations

Östgren, Carl Johan, Anna Norhammar, David Kylhammar, et al.. (2025). Aortic valve calcification across stages of dysglycemia in middle-aged individuals from the general population. Cardiovascular Diabetology. 24(1). 105–105. 3 indexed citations

Zachrisson, Helene, et al.. (2023). AB0577 LEFT VENTRICULAR DYSSYNCHRONY IN SUBJECTS WITH DIFFERENT SLE PHENOTYPES. Annals of the Rheumatic Diseases. 82. 1486–1486. 1 indexed citations

Kylhammar, David, Jan Engvall, Carl Johan Östgren, et al.. (2022). Post systolic shortening by speckle tracking echocardiography as a predictor for cardiovascular events in patients with type 2 diabetes. European Heart Journal. 43(Supplement_2).

Hjalmarsson, Clara, Barbro Kjellström, Kjell Jansson, et al.. (2021). Early risk prediction in idiopathicversusconnective tissue disease-associated pulmonary arterial hypertension: call for a refined assessment. ERJ Open Research. 7(3). 854–2020. 15 indexed citations

Kylhammar, David, Clara Hjalmarsson, Roger Hesselstrand, et al.. (2021). Predicting mortality during long-term follow-up in pulmonary arterial hypertension. ERJ Open Research. 7(2). 837–2020. 21 indexed citations

Kjellström, Barbro, Magnus Nisell, David Kylhammar, et al.. (2019). Sex-specific differences and survival in patients with idiopathic pulmonary arterial hypertension 2008–2016. ERJ Open Research. 5(3). 75–2019. 21 indexed citations

10.

Hjalmarsson, Clara, Göran Rådegran, David Kylhammar, et al.. (2018). Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension. European Respiratory Journal. 51(5). 1702310–1702310. 86 indexed citations

11.

Kylhammar, David, Roger Hesselstrand, Søren Nielsen, Camilla Schéele, & Göran Rådegran. (2018). Angiogenic and inflammatory biomarkers for screening and follow-up in patients with pulmonary arterial hypertension. Scandinavian Journal of Rheumatology. 47(4). 319–324. 28 indexed citations

12.

Kylhammar, David & Göran Rådegran. (2017). [Pulmonary hypertension due to lung diseases].. PubMed. 114.

13.

Schneede, Jørn, David Kylhammar, Dan Henrohn, et al.. (2017). Plasma l-arginine levels distinguish pulmonary arterial hypertension from left ventricular systolic dysfunction. Heart and Vessels. 33(3). 255–263. 20 indexed citations

14.

Kylhammar, David, Barbro Kjellström, Clara Hjalmarsson, et al.. (2017). A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension. European Heart Journal. 39(47). 4175–4181. 342 indexed citations breakdown →

15.

Kylhammar, David & Göran Rådegran. (2016). The principal pathways involved in thein vivomodulation of hypoxic pulmonary vasoconstriction, pulmonary arterial remodelling and pulmonary hypertension. Acta Physiologica. 219(4). 728–756. 63 indexed citations

16.

Kylhammar, David, et al.. (2014). Prognosis and response to first-line single and combination therapy in pulmonary arterial hypertension. Scandinavian Cardiovascular Journal. 48(4). 223–233. 21 indexed citations

17.

Kylhammar, David, et al.. (2014). P2Y1 and P2Y12 receptors in hypoxia- and adenosine diphosphate-induced pulmonary vasoconstriction in vivo in the pig. European Journal of Applied Physiology. 114(9). 1995–2006. 18 indexed citations

18.

Kylhammar, David, et al.. (2012). Levosimendan Attenuates Hypoxia-Induced Pulmonary Hypertension in a Porcine Model. Journal of Cardiovascular Pharmacology. 59(5). 441–449. 12 indexed citations

19.

Lundgren, Jakob, et al.. (2012). sGCstimulation totally reverses hypoxia‐induced pulmonary vasoconstriction alone and combined with dual endothelin‐receptor blockade in a porcine model. Acta Physiologica. 206(3). 178–194. 13 indexed citations

20.

Kylhammar, David, et al.. (2011). Dual endothelin receptor blockade with tezosentan markedly attenuates hypoxia‐induced pulmonary vasoconstriction in a porcine model. Acta Physiologica. 204(3). 419–434. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact